Embera NeuroTherapeutics is a development-stage pharmaceutical company developing treatments for smoking cessation and other addictions. Founded by Nicholas Edward Goeders in 2005, Embera NeuroTherapeutics is backed by investors that include National Institutes of Health, Keiretsu Capital, Keiretsu Forum Northwest, HRA Pharma, and National Institute on Drug Abuse (NIDA) and is headquartered in Sudbury.